1y return+20.8%S&P 500 +20.9%
These returns are for its stock picks as disclosed on Form 13F: last quarter's holdings, valued at this quarter's prices. They miss trades within each quarter, short positions, options, bonds, cash and fees, so they aren't the returns its clients got.
$100 invested in its stock picks
Since December 31, 2024: $136 against $127 in the S&P 500.2
Pfizer IncS&P 500 (SPY)
Top holdings
At the end of June 30, 2026. Change is in shares since the quarter before.2
| Stock | Value | Share of portfolio | Change |
|---|---|---|---|
| ALLOAllogene Therapeutics Inc | $46.9M | 27.5% | |
| CELCCelcuity Inc | $29.6M | 17.3% | |
| ARVNArvinas Inc | $27.7M | 16.2% | |
| PYXSPyxis Oncology Inc | $19.5M | 11.4% | |
| Wave Life Sciences LtdCUSIP Y95308105 | $10.9M | 6.4% | |
| Biohaven LtdCUSIP G1110E107 | $8.0M | 4.7% | |
| CRBUCaribou Biosciences Inc | $7.9M | 4.6% | |
| SPROSpero Therapeutics Inc | $5.3M | 3.1% | |
| ZNTLZentalis Pharmaceuticals Inc | $3.9M | 2.3% | |
| ORICOric Pharmaceuticals Inc | $3.6M | 2.1% | −92.2% |
| CRDFCardiff Oncology Inc | $3.0M | 1.8% | |
| Zura Bio LtdCUSIP G9TY5A101 | $2.9M | 1.7% | −81.0% |
| AGMBAgomab Therapeutics Nv | $1.0M | 0.6% | |
| BOLTBolt Biotherapeutics Inc | $134K | 0.1% | |
| NXTCNextcure Inc | $73K | 0.0% | −71.1% |
| DNAGinkgo Bioworks Holdings Inc | $30K | 0.0% | |
| Senseonics Hldgs IncCUSIP 81727U105 | $12K | 0.0% |
Best picks still held
How each current holding has done since the quarter it first appeared in its filings (up to six years back).
| Stock | Held since | Return since | Now worth |
|---|---|---|---|
| PYXSPyxis Oncology Inc | December 31, 2024 | +92.9% | $19.5M |
| ZNTLZentalis Pharmaceuticals Inc | December 31, 2024 | +60.1% | $3.9M |
| ORICOric Pharmaceuticals Inc | December 31, 2024 | +34.2% | $3.6M |
| AGMBAgomab Therapeutics Nv | March 31, 2026 | +23.7% | $1.0M |
| CRBUCaribou Biosciences Inc | December 31, 2024 | +10.7% | $7.9M |
| DNAGinkgo Bioworks Holdings Inc | December 31, 2024 | +0.9% | $30K |
| ALLOAllogene Therapeutics Inc | December 31, 2024 | −2.3% | $46.9M |
| BOLTBolt Biotherapeutics Inc | June 30, 2025 | −33.3% | $134K |
| Wave Life Sciences LtdCUSIP Y95308105 | December 31, 2024 | −53.0% | $10.9M |
| ARVNArvinas Inc | December 31, 2024 | −56.7% | $27.7M |
Sold off last quarter
- QTTBQ32 Bio Inc was $737K
Quarter by quarter
| Quarter | Its picks | S&P 500 |
|---|---|---|
| June 30, 2026 | −5.8% | +14.8% |
| March 31, 2026 | +14.6% | −4.6% |
| December 31, 2025 | +4.8% | +2.4% |
| September 30, 2025 | +6.8% | +7.8% |
| June 30, 2025 | +14.1% | +10.5% |
| March 31, 2025 | −1.5% | −4.6% |
Sources
Every number on this page points here. Each one links to the public record.
- 1SEC EDGAR: Pfizer Inc Form 13F filingshttps://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=78003&type=13F-HR&dateb=&owner=include&count=40CIK 78003
- 2SEC: 13F for the quarter ended June 30, 2026https://www.sec.gov/Archives/edgar/data/78003/000007800326000102/Filed August 13, 2026 · accession 0000078003-26-000102